Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Revenue

In the year 2023, Vanda Pharmaceuticals had annual revenue of $192.64M, a decrease of -24.27%. Revenue in the quarter ending December 31, 2023 was $45.27M, a -29.79% decrease year-over-year.

• Revenue (ttm): $192.64M
• Revenue Growth: -24.27%
• P/S Ratio: 1.44
• Revenue / Employee: $948,966
• Employees: 203
• Market Cap: 274.62M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	192.64M	-61.74M	-24.27%
Dec 31, 2022	254.38M	-14.30M	-5.32%
Dec 31, 2021	268.68M	20.51M	8.27%
Dec 31, 2020	248.17M	20.98M	9.23%
Dec 31, 2019	227.19M	34.07M	17.64%
Dec 31, 2018	193.12M	28.04M	16.98%
Dec 31, 2017	165.08M	19.07M	13.06%
Dec 31, 2016	146.02M	36.09M	32.83%
Dec 31, 2015	109.93M	59.77M	119.16%
Dec 31, 2014	50.16M	16.28M	48.05%
Dec 31, 2013	33.88M	1.15M	3.52%
Dec 31, 2012	32.73M	1.46M	4.66%
Dec 31, 2011	31.27M	-4.44M	-12.43%
Dec 31, 2010	35.71M	31.16M	685.16%
Dec 31, 2009	4.55M	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	0	-	-
Dec 31, 2006	0	-	-
Dec 31, 2005	0	-	-
Dec 31, 2004	33.98K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.